Boston Therapeutics and Prevail Infoworks announce strategic clinical partnership

|About: Boston Therapeutics Inc (BTHE)|By:, SA News Editor

Boston Therapeutics (OTCQB:BTHE) signed an agreement to collaborate with Prevail InfoWorks Single Interface Integrated Analytics Platform, to be employed in company’s recently initiated exploratory and adaptive multicenter clinical study of BTI320 in type 2 diabetes patients.

Prevail Partners, an investment fund, may allocate an investment of up to $500K by a stock purchases at a 25% premium to market price as part of the pending additional contracts for services.

Subscribe for full text news in your inbox